Inicio/Acciones/ARTV

ARTV

USD

Artiva Biotherapeutics Inc. Common Stock

$3.550-0.010 (-0.281%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$3.560

Máximo

$3.680

Mínimo

$3.510

Volumen

0.12M

Fundamentos de la Empresa

Capitalización de Mercado

86.7M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

2.12M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.47Actual $3.550Máximo $13.845

Noticias Relacionadas

3 nov 2025 · 21:05

GlobeNewswire

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

The virtual webcast will take place Wednesday, November 12, 2025, at 8 a.m. ET Initial safety data for 32 patients with autoimmune disease treated with AlloNK + monoclonal antibody (mAb) therapy, highlighting a

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

30 oct 2025 · 20:17

GlobeNewswire

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients